BofA/Merrill Lynch initiates coverage on Entellus Medical (NASDAQ: ENTL) with a Buy rating and a price target of $26.00.Analyst Bob ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE